Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
SLO
Login
Search
Browsing
Upload document
Statistics
RUP
FAMNIT - Faculty of Mathematics, Science and Information Technologies
FHŠ - Faculty of Humanities
FM - Faculty of Management
FTŠ Turistica - Turistica – College of Tourism Portorož
FVZ - Faculty of Health Sciences
IAM - Andrej Marušič Institute
PEF - Faculty of Education
UPR - University of Primorska
ZUP - University of Primorska Press
COBISS
University of Primorska, University Library - all departments
First page
/
Show document
Show document
A-
|
A+
|
Print
Title:
The editor's corner
Authors:
ID
Antončič, Boštjan
(Author)
Files:
http://www.fm-kp.si/zalozba/ISSN/1581-6311/6_339.pdf
Language:
English
Work type:
Not categorized
Typology:
1.20 - Preface, editorial, afterword
Organization:
FM - Faculty of Management
Keywords:
uvodniki
,
predgovori
Year of publishing:
2008
Number of pages:
str. 339
Numbering:
Vol. 6, no. 4
PID:
20.500.12556/RUP-1101
ISSN:
1581-6311
COBISS.SI-ID:
3037399
Publication date in RUP:
15.10.2013
Views:
2881
Downloads:
26
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
ANTONČIČ, Boštjan, 2008, The editor’s corner. In : [online]. Vol. 6, no. 4. [Accessed 3 April 2025]. Retrieved from: http://www.fm-kp.si/zalozba/ISSN/1581-6311/6_339.pdf
Copy citation
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:
Voting is allowed only for
logged in
users.
Share:
Similar works from our repository:
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN)
Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe
Similar works from other repositories:
Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Comments
Leave comment
You must
log in
to leave a comment.
Comments (0)
0 - 0 / 0
There are no comments!
Back